Prognostic Value of

Fusobacterium nucleatum anal squamous cell carcinoma cancer microenvironment intratumoral microbiota tumor biomarkers

Journal

Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829

Informations de publication

Date de publication:
22 Mar 2022
Historique:
received: 14 02 2022
revised: 14 03 2022
accepted: 16 03 2022
entrez: 12 4 2022
pubmed: 13 4 2022
medline: 13 4 2022
Statut: epublish

Résumé

Main prognostic factors of anal squamous cell carcinoma (ASCC) are tumor size, differentiation, lymph node involvement, and male gender. However, they are insufficient to predict relapses after exclusive radiotherapy (RT) or chemoradiotherapy (CRT).

Identifiants

pubmed: 35406380
pii: cancers14071606
doi: 10.3390/cancers14071606
pmc: PMC8997094
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

Clin Cancer Res. 2019 Oct 15;25(20):6170-6179
pubmed: 31358543
Oncoimmunology. 2019 Mar 27;8(6):e1581531
pubmed: 31069151
Sci Rep. 2021 Apr 12;11(1):7870
pubmed: 33846399
Sci Rep. 2020 Oct 1;10(1):16240
pubmed: 33004953
Transl Oncol. 2019 Jun;12(6):846-851
pubmed: 30986689
Br J Cancer. 2016 Jun 14;114(12):1387-94
pubmed: 27219019
Mod Pathol. 2021 Jan;34(1):116-130
pubmed: 32728225
Cancers (Basel). 2020 Nov 18;12(11):
pubmed: 33218162
CA Cancer J Clin. 2021 Jan;71(1):7-33
pubmed: 33433946
Science. 2020 May 29;368(6494):973-980
pubmed: 32467386
Ann Coloproctol. 2020 Dec;36(6):361-373
pubmed: 33486907
Hum Pathol. 2013 Jun;44(6):992-1002
pubmed: 23266444
Br J Cancer. 2017 Jan 17;116(2):156-162
pubmed: 27923035
Immunity. 2015 Feb 17;42(2):344-355
pubmed: 25680274
Clin Res Hepatol Gastroenterol. 2021 Mar;45(2):101589
pubmed: 33607375
Radiother Oncol. 2014 Dec;113(3):352-8
pubmed: 25499203
Int J Health Sci (Qassim). 2012 Jun;6(2):206-30
pubmed: 23580899
Nat Rev Clin Oncol. 2018 Jun;15(6):382-396
pubmed: 29636538
Gut. 2016 Dec;65(12):1973-1980
pubmed: 26311717
World J Gastrointest Oncol. 2018 Mar 15;10(3):71-81
pubmed: 29564037
Ann Oncol. 2014 Sep;25 Suppl 3:iii10-20
pubmed: 25001200
Dig Liver Dis. 2017 Aug;49(8):831-840
pubmed: 28610905
World J Gastroenterol. 2016 Jan 14;22(2):557-66
pubmed: 26811607
Clin Oncol (R Coll Radiol). 2021 Oct;33(10):638-649
pubmed: 34024700
Ann Oncol. 2020 Oct;31(10):1366-1375
pubmed: 32569727
Oncotarget. 2015 Mar 30;6(9):7209-20
pubmed: 25797243
Eur J Cancer. 2013 Mar;49(4):769-81
pubmed: 23122780

Auteurs

Marc Hilmi (M)

Medical Oncology Department, Institut Curie, 92210 Saint-Cloud, France.

Cindy Neuzillet (C)

Medical Oncology Department, Institut Curie, 92210 Saint-Cloud, France.

Jérémie H Lefèvre (JH)

Digestive Surgery Department, Hôpital Saint-Antoine, AP-HP, Sorbonne Université, 75012 Paris, France.

Magali Svrcek (M)

Pathology Department, Hôpital Saint-Antoine, AP-HP, 75012 Paris, France.

Sophie Vacher (S)

Genetics Department, Institut Curie, 75005 Paris, France.

Leonor Benhaim (L)

Digestive Surgery Department, Gustave Roussy Institute, 94800 Villejuif, France.

Peggy Dartigues (P)

Pathology Department, Gustave Roussy Institute, 94800 Villejuif, France.

Emmanuelle Samalin (E)

Medical Oncology Department, Institut du Cancer de Montpellier (ICM), University of Montpellier, 34000 Montpellier, France.

Julien Lazartigues (J)

Gastroenterology Department, Hôpital Ambroise Paré, AP-HP, 92100 Boulogne-Billancourt, France.

Jean-François Emile (JF)

Pathology Department, Hôpital Ambroise Paré, AP-HP, Université de Versailles SQY, 92100 Boulogne-Billancourt, France.

Eugénie Rigault (E)

Gastroenterology Department, Rennes University Hospital, 35200 Rennes, France.
Medical Oncology Department, Gustave Roussy Institute, 94800 Villejuif, France.

Nathalie Rioux-Leclercq (N)

Pathology Department, Rennes University Hospital, 35200 Rennes, France.

Christelle de La Fouchardière (C)

Medical Oncology Department, Centre Léon Bérard, 69000 Lyon, France.

David Tougeron (D)

Department of Gastroenterology and Hepatology, Poitiers University Hospital, 86073 Poitiers, France.

Wulfran Cacheux (W)

Medical Oncology Department, Hôpital Privé Pays de Savoie, 74000 Annemasse, France.

Pascale Mariani (P)

Surgical Oncology Department, Institut Curie, 75005 Paris, France.

Laura Courtois (L)

Genetics Department, Institut Curie, 75005 Paris, France.

Matthieu Delaye (M)

Medical Oncology Department, Institut Curie, 92210 Saint-Cloud, France.

Virginie Dangles-Marie (V)

Faculty of Pharmacy, Université de Paris, 75019 Paris, France.
Laboratory of Preclinical Investigation, Translational Research Department, Institut Curie, PSL Research University, 75006 Paris, France.

Astrid Lièvre (A)

Gastroenterology Department, Rennes University Hospital, 35200 Rennes, France.
Inserm U1242, COSS (Chemistry Oncogenesis Stress Signaling), Rennes 1 University, 35000 Rennes, France.

Ivan Bieche (I)

Genetics Department, Institut Curie, 75005 Paris, France.

Classifications MeSH